(Q39112374)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

main subject

neoplastic invasiveness

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Joon Jeong

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Seung Myung Dong

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Akira Oshima

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Woo Ho Kim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Hak Min Lee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Seung Ah Lee

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Seung-Hyun Kwon

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Ji-Hae Lee

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Jae Myun Lee

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Hy-De Lee

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Jeffrey E Green

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

language of work or name

English

0 references

publication date

10 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

141

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

89-99

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-013-2662-3

7 March 2020

exact match

0 references

cites work

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

Novel therapeutic approaches to the treatment of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

A novel human lysyl oxidase-like gene (LOXL4) on chromosome 10q24 has an altered scavenger receptor cysteine rich domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

Central nervous system, uterus, heart, and leukocyte expression of the LOXL3 gene, encoding a novel lysyl oxidase-like protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

A new gene with sequence and structural similarity to the gene encoding human lysyl oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

Regulation of a novel gene encoding a lysyl oxidase-related protein in cellular adhesion and senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

Lysyl oxidase-like 2 expression is increased in colon and esophageal tumors and associated with less differentiated colon tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

TIMP-1 expression in human colorectal cancer is associated with TGF-B1, LOXL2, INHBA1, TNF-AIP6 and TIMP-2 transcript profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

Functional analysis of LOXL2 in pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

RETRACTED: Lysyl oxidase is essential for hypoxia-induced metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

LOXL2-mediated matrix remodeling in metastasis and mammary gland involution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

The rationale for targeting the LOX family in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

A molecular role for lysyl oxidase-like 2 enzyme in snail regulation and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

Lysyl oxidase-like 2 (LOXL2), a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

Epithelial to mesenchymal transition and breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

Triple-negative breast cancer: clinical features and patterns of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

Triple-Negative Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

A novel asymmetric 3D in-vitro assay for the study of tumor cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

Lysyl oxidase-like 2 promotes migration in noninvasive breast cancer cells but not in normal breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2662-3

Lysyl oxidase-related protein-1 promotes tumor fibrosis and tumor progression in vivo

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23933800

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23933800

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S10549-013-2662-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23933800%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

PubMed publication ID

23933800

1 reference